First-in-Human(FIH)Trialat36Months:37% reduction in mean intraocular pressure (IOP) in evaluable patients across all dose ...
SpyGlass Pharma has released positive data from 2 trials of its lead candidate, the Bimatoprost Drug Pad-IOL System (BIM-IOL ...
Avisi Technologies has released positive 12-month clinical data on the VisiPlate Aqueous Shunt from the VITA Trial. The VITA ...
Please provide your email address to receive an email when new articles are posted on . Patients with migraine aged younger than 40 years had higher risk for open-angle glaucoma onset vs. those aged ...
Nova Eye Medical Ltd (($ELXMF)) announced an update on their ongoing clinical study. Study Overview: Nova Eye Medical Ltd is conducting a clinical ...
A risk score incorporating genetic variants for open-angle glaucoma is accurate enough to help with diagnosis of the condition, an interim study reveals. Although hundreds of genetic changes are ...
DelveInsight's“ Open-angle Glaucoma Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Open-angle Glaucoma pipeline landscape. It covers ...
Please provide your email address to receive an email when new articles are posted on . The safety and efficacy of selective laser trabeculoplasty was comparable to argon laser trabeculoplasty. Data ...
University of Missouri researchers have discovered two potential biomarkers of glaucoma – agmatine and thiamine ...
Elevated systolic blood pressure (BP) and pulse pressure were associated with an increased risk of incident primary open-angle glaucoma. There was no significant association between diastolic BP and ...